Literature DB >> 16650626

Midzonal lesions in yellow fever: a specific pattern of liver injury caused by direct virus action and in situ inflammatory response.

Juarez A S Quaresma1, Maria I S Duarte, Pedro F C Vasconcelos.   

Abstract

Yellow fever is an acute infectious, non-contagious disease characterized by intense vasculopathy and lesions in different organs. In the liver, one of the main targets of the virus, the infection induces a characteristic midzonal injury characterized by hepatocyte necrosis, apoptosis and steatosis. This characteristics pattern of liver injury in yellow fever is also observed in conditions of low-flow hypoxia and other infections such as dengue and Rift Valley fever. There are no reports in the literature explaining the genesis of this peculiar histopathological pattern in yellow fever. Some hypotheses have been proposed to explain the mechanism of this midzonal distribution pattern observed in the liver such as low-flow hypoxia and tropism of the virus toward hepatocytes in this area. These hypotheses are discussed in view of more recent findings regarding the pathogenesis of yellow fever and regarding hepatic physiopathology, and a new hypothesis is proposed: the midzonal necrosis is consequence of action of combined factors mainly the direct cytopathic effect of YFV associated with a potent immune response in which CD4+ and CD8+ lymphocytes and the cytokines, especially TGF-beta, but also TNF-alpha and IFN-gamma play an important role.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16650626     DOI: 10.1016/j.mehy.2006.01.060

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  11 in total

1.  Factors Involved in the Apoptotic Cell Death Mechanism in Yellow Fever Hepatitis.

Authors:  Jeferson da Costa Lopes; Luiz Fábio Magno Falcão; Arnaldo Jorge Martins Filho; Marcos Luiz Gaia Carvalho; Caio Cesar Henriques Mendes; Fábio Alves Olímpio; Vanessa do Socorro Cabral Miranda; Lais Carneiro Dos Santos; Jannifer Oliveira Chiang; Ana Cecilia Ribeiro Cruz; Vanessa Costa Alves Galúcio; Raimunda do Socorro da Silva Azevedo; Lívia Caricio Martins; Maria Irma Seixas Duarte; Jorge Rodrigues de Sousa; Pedro Fernando da Costa Vasconcelos; Juarez Antônio Simões Quaresma
Journal:  Viruses       Date:  2022-06-01       Impact factor: 5.818

2.  Fatal outcome of hepatitis A virus (HAV) infection in a traveler with incomplete HAV vaccination and evidence of Rift Valley Fever virus infection.

Authors:  Anke Oltmann; Stephanie Kämper; Oliver Staeck; Jonas Schmidt-Chanasit; Stephan Günther; Thomas Berg; Christina Frank; Detlev H Krüger; Jörg Hofmann
Journal:  J Clin Microbiol       Date:  2008-09-03       Impact factor: 5.948

Review 3.  Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe.

Authors:  Florian Douam; Alexander Ploss
Journal:  Trends Microbiol       Date:  2018-06-19       Impact factor: 17.079

Review 4.  T Cell-Mediated Immunity towards Yellow Fever Virus and Useful Animal Models.

Authors:  Alan M Watson; William B Klimstra
Journal:  Viruses       Date:  2017-04-11       Impact factor: 5.048

5.  Analysis By Deep Sequencing of Discontinued Neurotropic Yellow Fever Vaccine Strains.

Authors:  Andrew S Beck; Thomas G Wood; Steven G Widen; Jill K Thompson; Alan D T Barrett
Journal:  Sci Rep       Date:  2018-09-07       Impact factor: 4.379

Review 6.  What Does the Future Hold for Yellow Fever Virus? (II).

Authors:  Raphaëlle Klitting; Carlo Fischer; Jan F Drexler; Ernest A Gould; David Roiz; Christophe Paupy; Xavier de Lamballerie
Journal:  Genes (Basel)       Date:  2018-08-21       Impact factor: 4.096

7.  Aedes mosquito saliva modulates Rift Valley fever virus pathogenicity.

Authors:  Alain Le Coupanec; Divya Babin; Laurence Fiette; Grégory Jouvion; Patrick Ave; Dorothee Misse; Michèle Bouloy; Valerie Choumet
Journal:  PLoS Negl Trop Dis       Date:  2013-06-13

8.  The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+ but not CD8+ T Cells.

Authors:  Alan M Watson; L K Metthew Lam; William B Klimstra; Kate D Ryman
Journal:  PLoS Pathog       Date:  2016-07-27       Impact factor: 6.823

9.  Yellow Fever Vaccination in a Mouse Model Is Associated With Uninterrupted Pregnancies and Viable Neonates Except When Administered at Implantation Period.

Authors:  Fernanda C da Silva; Fernanda M Magaldi; Helena K Sato; Estela Bevilacqua
Journal:  Front Microbiol       Date:  2020-02-20       Impact factor: 5.640

10.  Endothelium Activation during Severe Yellow Fever Triggers an Intense Cytokine-Mediated Inflammatory Response in the Liver Parenchyma.

Authors:  Fábio Alves Olímpio; Luiz Fábio Magno Falcão; Marcos Luiz Gaia Carvalho; Jeferson da Costa Lopes; Caio Cesar Henriques Mendes; Arnaldo Jorge Martins Filho; Carlos Augusto Moreira da Silva; Vanessa do Socorro Cabral Miranda; Lais Carneiro Dos Santos; Fellipe Souza da Silva Vilacoert; Ana Cecília Ribeiro Cruz; Vanessa Costa Alves Galúcio; Raimunda do Socorro da Silva Azevedo; Lívia Caricio Martins; Maria Irma Seixas Duarte; Jorge Rodrigues de Sousa; Pedro Fernando da Costa Vasconcelos; Juarez Antônio Simões Quaresma
Journal:  Pathogens       Date:  2022-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.